Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chronic hepatitis C - what do the new drugs offer and who should get them first?

Clinical medicine (London, England) - 1 Apr 2015

Ryder Stephen D

Abstract excerpt

Until recently in the UK the treatment of HCV depended on combination regimes of interferon (IFN) and the antiviral drug ribavirin. These regimes required regular injections and were of variable duration (generally for a minimum of 12 weeks), and the use of IFN often caused unacceptable side effe...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Genotype
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Source

Open in PubMed Open full text

Identifiers

PMID: 25824075
DOI: 10.7861/clinmedicine.15-2-197
PMCID: PMC4953742

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25824075-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chronic hepatitis C - what do the new drugs offer and who should get them first?PMID 25824075Read ↗

Current therapy for chronic hepatitis C: The role of direct-acting antivirals.Semantic proximity Read ↗

New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives.Semantic proximity Read ↗

What does the pharmacological future of treating chronic hepatitis C look like?Semantic proximity Read ↗

Treatment of hepatitis C in patients with cirrhosis: remaining challenges for direct-acting antiviral therapy.Semantic proximity Read ↗

New treatments for chronic hepatitis C virus infection.Semantic proximity Read ↗

Improving the treatment of hepatitis C infection in the UK.Semantic proximity Read ↗

Second generation direct-acting antivirals - Do we expect major improvements?Semantic proximity Read ↗

Direct-acting antivirals for acute HCV: how short can we go?Semantic proximity Read ↗

Current and Evolving Treatments of Genotype 1 Hepatitis C Virus.Semantic proximity Read ↗

Chronic hepatitis C genotype 1 virus: who should wait for treatment?Semantic proximity Read ↗

Direct-acting antiviral therapy for hepatitis C: The initial experience of the University of Cape Town/Groote Schuur Hospital Liver Clinic, South Africa.Semantic proximity Read ↗

Current therapy for hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.